Torii Pharmaceutical Co., Ltd.

Tokyo Stock Exchange 4551.T

Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.00

Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio is 0.00 for the year ending December 31, 2023, a -53.79% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.00, a 5.82% change year over year.
Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.00, a 62.59% change year over year.
Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.00, a -23.75% change year over year.
Torii Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.00, a -37.25% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Tokyo Stock Exchange: 4551.T

Torii Pharmaceutical Co., Ltd.

CEO	Mr. Goichi Matsuda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	Torii Nihonbashi Bldg.
Employees	583
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Pet Food Pharmaceuticals Tobacco

Description

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Key trends

Past 5 years